Riskpilot← Back to searchSign inGet full accessINNOVENTA MEDICA ApS
APSActiveCVR 30801725Blokken 45Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20074 employees
Revenue 2024
DKK 1,9M
+39% vs 2023
EBITDA margin
29.8%
+80% vs 2023
Equity ratio
69.6%
Financial strength
Net profit 2024
DKK -172K
-166% vs 2023
| Revenue | DKK 1,9M | +39% |
| EBITDA | DKK 574K | +80% |
| Net profit | DKK -172K | -166% |
| Total assets | DKK 3,5M | -12% |
| Equity | DKK 2,4M | -7% |
| Employees | 4 | — |
Legal name
INNOVENTA MEDICA ApS
CVR number
30801725
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
16. august 2007
Share capital
DKK 150.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden eller af en direktør hver for sig
Company purpose
Selskabets formål er at udvikle, registrere, producere og distribuere medicinsk udstyr.
Address
Blokken 45
Phone
+4545812465
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 728 | 1.446 | 1.901 | 1.391 | 1.929 |
| Staff expenses | -1.011 | -963 | -1.047 | -1.072 | -1.355 |
| EBITDA | -283 | 483 | 854 | 319 | 574 |
| Depreciation & amort. | -2 | -22 | -22 | -25 | -41 |
| EBIT | -285 | 461 | 832 | 294 | 534 |
| Net financials | 382 | 683 | 5 | 40 | -657 |
| Profit before tax | -589 | -170 | 837 | 333 | -124 |
| Tax | -122 | 56 | 184 | 74 | 48 |
| Net profit | -467 | -226 | 653 | 259 | -172 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.705 | 2.798 | 3.484 | 3.967 | 3.481 |
| Equity | 1.908 | 1.681 | 2.334 | 2.593 | 2.421 |
| Long-term debt | 73 | 0 | 0 | 0 | 0 |
| Short-term debt | 725 | 1.064 | 1.134 | 1.353 | 1.060 |
| Total debt | 798 | 1.064 | 1.134 | 1.353 | 1.060 |
EBITDA margin
29.8%
This company
15.8%
Market median
+89% vs market
20202024
Equity ratio
69.6%
This company
38.2%
Market median
+82% vs market
20202024
Return on equity
-7.1%
This company
18.4%
Market median
-139% vs market
20202024
Net profit margin
-8.9%
This company
8.1%
Market median
-210% vs market
20202024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20202024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NE Management | Management | 2007 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2007 – 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66.67–89.99% | 66.67–89.99% | 2017 | |
| Individual | 20–24.99% | 20–24.99% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
N. E. HOLM A/S
INNOVENTA MEDICA ApS Board members of INNOVENTA MEDICA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Erik Holm | Management | 0 companies |
| John Hørby | Board of Directors | 0 companies |